RxDoctor Payments Data

Timothy Cooper

Family Medicine · Putnam, CTNPI 1003860891

Payments from drug & device makers

$948in general payments, 2019–2025

Across 57 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$134
  • Novo Nordisk$124
  • AstraZeneca$115
  • Pfizer$98
  • E.r. Squibb & Sons, L.L.C.$83
  • Boehringer Ingelheim$61
  • plus $331 from 9 others

What the payments were for

  • Food & beverage$947100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948 in reported general payments places this provider in the 70th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$88,664
Medicare patients
147
Services billed
3,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban98$119,611
TrulicityDulaglutide34$68,350
JanuviaSitagliptin Phosphate35$43,180
JardianceEmpagliflozin19$26,034
Repatha SureclickEvolocumab19$21,931
OzempicSemaglutide17$21,491
XareltoRivaroxaban14$19,120
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$15,590
SymbicortBudesonide/Formoterol Fumarate29$10,890
MyrbetriqMirabegron11$9,945
PremarinEstrogens, Conjugated14$7,138
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,167
Risedronate Sodium29$4,936
Levothyroxine Sodium318$4,176
Oxycodone Hcl108$4,172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$98$126,749112 claims
Lilly USA, LLCTrulicity$34$68,35034 claims
MerckJanuvia$32$43,18035 claims
Boehringer IngelheimJardiance, Stiolto Respimat$61$31,20130 claims
Novo NordiskOzempic$124$21,49117 claims
GSKTrelegy Ellipta$134$15,59012 claims
AstraZenecaSymbicort$115$10,89029 claims
Astellas Pharma US IncMyrbetriq$55$9,94511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 588 family medicine providers in Connecticut.

Other family medicine in Putnam

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →